Recent Patents on Inflammation & Allergy Drug Discovery publishes full-length/mini reviews and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of inflammation and allergy drug discovery e.g. on novel bioactive compounds, analogs and targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in inflammation and allergy drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to inflammation and allergy drug discovery.
Jinyong Peng College of Pharmacy Dalian Medical University Dalian (China)
Jinyong Peng received his Master of Medical Science from Zhejiang University,
received PhD from The Second Military Medical University, Shanghai, and received
his post-doctoral degree from Dalian Institute of Chemical Physics, Chinese Academy
of Sciences, Dalian, China. Currently, he is working as one Professor and the Dean of
College of Pharmacy, Dalian Medical University, Dalian China. He is serving as EBM of
Br J Pharmacol, Arch Toxicol, Pharmacol Res, Toxicol Appl Pharmacol,
Phytomedicine, and so on. He has published more than 100 papers in some famous
journals. His research interest is to investigate the targets, activities, toxicology and
mechanisms of natural products for drug discovery on the treatment of Organ
damage and metabolic diseases.